Other approaches include the fusion of AnxA1-derived peptides with a cell-penetrating peptide to protect against neuronal apoptosis after cerebral ischemia [85], or the grafting of a small bioactive AnxA1 peptide into a stable cyclic peptide scaffold for the reduction of inflammation in a mouse model for acute colitis [86]. Here, ANXA1 is linked to Cerebral ischemia.